DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,023,637 | +27.2% | 4,126 | +23.1% | 0.04% | +32.4% |
| Q2 2023 | $804,840 | -18.3% | 3,351 | -14.2% | 0.03% | -22.7% |
| Q1 2023 | $985,251 | -7.9% | 3,906 | -3.1% | 0.04% | -12.0% |
| Q4 2022 | $1,069,973 | +4.9% | 4,029 | +2.0% | 0.05% | -5.7% |
| Q3 2022 | $1,020,000 | +35.1% | 3,951 | +32.8% | 0.05% | +35.9% |
| Q2 2022 | $755,000 | -18.0% | 2,975 | -5.3% | 0.04% | +5.4% |
| Q1 2022 | $921,000 | -10.4% | 3,140 | +0.5% | 0.04% | -9.8% |
| Q4 2021 | $1,028,000 | +23.6% | 3,125 | +14.3% | 0.04% | +7.9% |
| Q3 2021 | $832,000 | +17.2% | 2,733 | +3.3% | 0.04% | +11.8% |
| Q2 2021 | $710,000 | +39.5% | 2,645 | +17.0% | 0.03% | +30.8% |
| Q1 2021 | $509,000 | +27.9% | 2,261 | +26.2% | 0.03% | +13.0% |
| Q4 2020 | $398,000 | -13.3% | 1,792 | -15.9% | 0.02% | -28.1% |
| Q3 2020 | $459,000 | +27.5% | 2,130 | +4.6% | 0.03% | +18.5% |
| Q2 2020 | $360,000 | -47.1% | 2,036 | -58.6% | 0.03% | -57.1% |
| Q1 2020 | $680,000 | -23.4% | 4,915 | -15.0% | 0.06% | -14.9% |
| Q4 2019 | $888,000 | +7.2% | 5,783 | +0.8% | 0.07% | -3.9% |
| Q3 2019 | $828,000 | +1.0% | 5,735 | 0.0% | 0.08% | -1.3% |
| Q2 2019 | $820,000 | +21.8% | 5,735 | +12.5% | 0.08% | +14.7% |
| Q1 2019 | $673,000 | +37.1% | 5,096 | +7.1% | 0.07% | +33.3% |
| Q4 2018 | $491,000 | -5.6% | 4,759 | -0.6% | 0.05% | +10.9% |
| Q3 2018 | $520,000 | +11.3% | 4,787 | +1.2% | 0.05% | +4.5% |
| Q2 2018 | $467,000 | 0.0% | 4,731 | -0.9% | 0.04% | -2.2% |
| Q1 2018 | $467,000 | – | 4,774 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |